-Rocket Pharmaceuticals Announces Updated Positive Preliminary Clinical Data from Phase 1 Trial of RP-L301 for the Treatment of Pyruvate Kinase Deficiency

  • Jonathan Schwartz,

Press/Media

Period23 Mar 2021

Media coverage

1

Media coverage

  • Title-Rocket Pharmaceuticals Announces Updated Positive Preliminary Clinical Data from Phase 1 Trial of RP-L301 for the Treatment of Pyruvate Kinase Deficiency
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date23/03/21
    PersonsJonathan Schwartz,
View all 1
View less